Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1990 Feb 3;300(6720):277–278. doi: 10.1136/bmj.300.6720.277

Vigabatrin.

E H Reynolds 1
PMCID: PMC1661912  PMID: 2106955

Full text

PDF
277

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Butler W. H., Ford G. P., Newberne J. W. A study of the effects of vigabatrin on the central nervous system and retina of Sprague Dawley and Lister-Hooded rats. Toxicol Pathol. 1987;15(2):143–148. doi: 10.1177/019262338701500203. [DOI] [PubMed] [Google Scholar]
  2. Gram L., Klosterskov P., Dam M. gamma-Vinyl GABA: a double-blind placebo-controlled trial in partial epilepsy. Ann Neurol. 1985 Mar;17(3):262–266. doi: 10.1002/ana.410170307. [DOI] [PubMed] [Google Scholar]
  3. Iadarola M. J., Gale K. Cellular compartments of GABA in brain and their relationship to anticonvulsant activity. Mol Cell Biochem. 1981 Sep 25;39:305–329. doi: 10.1007/BF00232582. [DOI] [PubMed] [Google Scholar]
  4. Jung M. J., Lippert B., Metcalf B. W., Böhlen P., Schechter P. J. gamma-Vinyl GABA (4-amino-hex-5-enoic acid), a new selective irreversible inhibitor of GABA-T: effects on brain GABA metabolism in mice. J Neurochem. 1977 Nov;29(5):797–802. doi: 10.1111/j.1471-4159.1977.tb10721.x. [DOI] [PubMed] [Google Scholar]
  5. Loiseau P., Hardenberg J. P., Pestre M., Guyot M., Schechter P. J., Tell G. P. Double-blind, placebo-controlled study of vigabatrin (gamma-vinyl GABA) in drug-resistant epilepsy. Epilepsia. 1986 Mar-Apr;27(2):115–120. doi: 10.1111/j.1528-1157.1986.tb03512.x. [DOI] [PubMed] [Google Scholar]
  6. Meldrum B. Amino acid neurotransmitters and new approaches to anticonvulsant drug action. Epilepsia. 1984;25 (Suppl 2):S140–S149. doi: 10.1111/j.1528-1157.1984.tb05646.x. [DOI] [PubMed] [Google Scholar]
  7. Pedersen S. A., Klosterskov P., Gram L., Dam M. Long-term study of gamma-vinyl GABA in the treatment of epilepsy. Acta Neurol Scand. 1985 Sep;72(3):295–298. doi: 10.1111/j.1600-0404.1985.tb00873.x. [DOI] [PubMed] [Google Scholar]
  8. Perry T. L., Kish S. J., Hansen S. gamma-Vinyl GABA: effects of chronic administration on the metabolism of GABA and other amino compounds in rat brain. J Neurochem. 1979 Jun;32(6):1641–1645. doi: 10.1111/j.1471-4159.1979.tb02274.x. [DOI] [PubMed] [Google Scholar]
  9. Reynolds E. H., Ring H., Heller A. A controlled trial of gamma-vinyl-GABA (vigabatrin) in drug-resistant epilepsy. Br J Clin Pract Suppl. 1988 Mar;61:33–33. [PubMed] [Google Scholar]
  10. Rimmer E. M., Richens A. Double-blind study of gamma-vinyl GABA in patients with refractory epilepsy. Lancet. 1984 Jan 28;1(8370):189–190. doi: 10.1016/s0140-6736(84)92112-3. [DOI] [PubMed] [Google Scholar]
  11. Schechter P. J., Hanke N. F., Grove J., Huebert N., Sjoerdsma A. Biochemical and clinical effects of gamma-vinyl GABA in patients with epilepsy. Neurology. 1984 Feb;34(2):182–186. doi: 10.1212/wnl.34.2.182. [DOI] [PubMed] [Google Scholar]
  12. Tartara A., Manni R., Galimberti C. A., Hardenberg J., Orwin J., Perucca E. Vigabatrin in the treatment of epilepsy: a double-blind, placebo-controlled study. Epilepsia. 1986 Nov-Dec;27(6):717–723. doi: 10.1111/j.1528-1157.1986.tb03600.x. [DOI] [PubMed] [Google Scholar]
  13. Tassinari C. A., Michelucci R., Ambrosetto G., Salvi F. Double-blind study of vigabatrin in the treatment of drug-resistant epilepsy. Arch Neurol. 1987 Sep;44(9):907–910. doi: 10.1001/archneur.1987.00520210009010. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES